It is not known whether CXCL12 and MIF are increased in lungs of irradiated breast cancer patients but future research could investigate the sputum, serum or urine of breast cancer patients in the acute or long-term response to radiation. This evidence concerns the gene CXCL12 and breast carcinoma.